Top compounds associated with response to LRRC47


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC -0.028 0.5
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.029 0.5
mRNA NU-7441 GDSC1000 pan-cancer AAC 0.026 0.5
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC 0.037 0.5
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.033 0.5
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.023 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA SB 216763 GDSC1000 pan-cancer AAC 0.027 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA AC220 GDSC1000 pan-cancer AAC 0.024 0.5
Download CSV